Literature DB >> 6163372

The interferon-induced enzyme oligo-isoadenylate synthetase: rapid determination of its in vitro products.

G Merlin, M Revel, D Wallach.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6163372     DOI： 10.1016/0003-2697(81)90134-2

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  15 in total

1.  Treatment with human recombinant leukocyte interferons inhibits in vitro invasive ability of human lung carcinoma cells.

Authors:  T J Ravine; N Ledinko
Journal:  Clin Exp Metastasis       Date:  1986 Jul-Sep       Impact factor: 5.150

2.  Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.

Authors:  E C Short; R W Fulton
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

3.  De novo synthesis and secretion of a 36-kD protein by cells that form lupus inclusions in response to alpha-interferon.

Authors:  S A Rich
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

4.  Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells.

Authors:  M Fellous; U Nir; D Wallach; G Merlin; M Rubinstein; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  Intracellular human gamma-interferon triggers an antiviral state in transformed murine L cells.

Authors:  J Sancéau; P Sondermeyer; F Béranger; R Falcoff; C Vaquero
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Differential modulating effects of retinoic acid on interferon antiviral activity.

Authors:  C K Ho; B R Ou; C Y Wang; H Y Chen; T Kuwata
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.

Authors:  A Schattner; G Merlin; V Bregman; T Hahn; S Levin; M Revel; D Wallach
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

8.  Clinical effect of interferon in malignant brain tumours.

Authors:  M Nagai; T Arai
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

9.  Tumor necrosis factor alpha modifies resistance to interferon alpha in vivo: first clinical data.

Authors:  T Moritz; O Kloke; M Nagel-Hiemke; G Kummer; U B Wandl; B Opalka; B Plappert; J Kempeni; S Seeber; N Niederle
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

10.  Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta.

Authors:  J Content; L De Wit; D Pierard; R Derynck; E De Clercq; W Fiers
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.